Last reviewed · How we verify
Lumbar plexus block
At a glance
| Generic name | Lumbar plexus block |
|---|---|
| Sponsor | Wake Forest University Health Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of the Quadratus Lumborum Block Versus the Lumbar Plexus for Spiral Thighplasty Surgery (NA)
- Lumbar-Sacral Plexus Block vs Fascia Iliaca Block Plus Low-Dose Spinal Anesthesia for Femoral Neck Fracture Surgery (NA)
- Quadratus Lumborum vs Erector Spinae Supplementary Blocks With Lumbar Plexus Blocks for Hip PAO (PHASE4)
- Comparison of Unilateral Spinal Anesthesia and Nerve Block in Hip Fractures (NA)
- The Erector Spinae Plane Block For Gastrointestinal Malignancy Pain Treatment (EGIPT) (NA)
- Neurological Events and Unforeseen Risks After Locoregional-anesthesia
- Comparison of Regional Anaesthesia Methods for Femoral Neck Fracture Surgery (NA)
- Postoperative Analgesia in Hip Arthroplasty (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Lumbar plexus block CI brief — competitive landscape report
- Lumbar plexus block updates RSS · CI watch RSS
- Wake Forest University Health Sciences portfolio CI